BrainsWay Ltd.

Tel Aviv Stock Exchange BWAY.TA

BrainsWay Ltd. Free Cash Flow Per Share for the year ending December 31, 2023: USD -0.03

BrainsWay Ltd. Free Cash Flow Per Share is USD -0.03 for the year ending December 31, 2023, a 86.91% change year over year. Free cash flow per share is the free cash flow generated per share. Indicates investment potential based on cash flow generation.

BrainsWay Ltd. Free Cash Flow Per Share for the year ending December 31, 2022 was USD -0.25, a -484.96% change year over year.
BrainsWay Ltd. Free Cash Flow Per Share for the year ending December 31, 2021 was USD -0.04, a 75.03% change year over year.
BrainsWay Ltd. Free Cash Flow Per Share for the year ending December 31, 2020 was USD -0.17, a 66.18% change year over year.
BrainsWay Ltd. Free Cash Flow Per Share for the year ending December 31, 2019 was USD -0.51, a -49.09% change year over year.

Key data

Date	Free Cash Flow Per Share	Return on Assets (ROA)	Return on Equity (ROE)	Return on Capital Employed (ROCE)

Tel Aviv Stock Exchange: BWAY.TA

BrainsWay Ltd.

CEO	Mr. Hadar Levy
IPO Date	March 28, 2007
Location	Israel
Headquarters	Bynet Building
Employees	134
Sector	Healthcare
Industries Mental Health Biotechnology Pharmaceuticals

Description

Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company primarily serves doctors, hospitals, and medical centers in the field of psychiatry. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.

Key trends

Past 5 years